Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harrington

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Nature Medicine|January 10, 2023
The 1/4/6x24 campaign to cure tuberculosis quicklyLindsay McKenna, Mike Frick, Ketholelie Angami, et al.
Science (New York, N.Y.)|October 1, 2005
AIDS. Promote HIV chemoprophylaxis research, don't prevent itRobert M Grant, Susan Buchbinder, Willard Cates, et al.
Lancet (London, England)|May 22, 2010
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to actionBen J Marais, Mario C Raviglione, Peter R Donald, et al.
Contemporary Clinical Trials|September 24, 2025
Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trialMichelle A Kendall, Michael D Hughes, Soyeon Kim, et al.
Environmental Health Perspectives|May 4, 2005
Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthmaLora E Fleming, Barbara Kirkpatrick, Lorraine C Backer, et al.
Harmful Algae 2002 : Proceedings of the Xth International Conference on Harmful Algae, St. Pete Beach, Florida, USA, October 21-25, 2002. International Conference on Harmful Algae (10Th : 2002 : St. Pete Beach, Florida)|October 6, 2015
An Epidemiologic Approach to the Study of Aerosolized Florida Red TidesLora E Fleming, Lorraine C Backer, Barbara Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Lancet (London, England)|September 16, 2023
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on TuberculosisMichael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Nature Medicine|January 10, 2023
The 1/4/6x24 campaign to cure tuberculosis quicklyLindsay McKenna, Mike Frick, Ketholelie Angami, et al.
Science (New York, N.Y.)|October 1, 2005
AIDS. Promote HIV chemoprophylaxis research, don't prevent itRobert M Grant, Susan Buchbinder, Willard Cates, et al.
Lancet (London, England)|May 22, 2010
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to actionBen J Marais, Mario C Raviglione, Peter R Donald, et al.
Contemporary Clinical Trials|September 24, 2025
Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trialMichelle A Kendall, Michael D Hughes, Soyeon Kim, et al.
Environmental Health Perspectives|May 4, 2005
Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthmaLora E Fleming, Barbara Kirkpatrick, Lorraine C Backer, et al.
Harmful Algae 2002 : Proceedings of the Xth International Conference on Harmful Algae, St. Pete Beach, Florida, USA, October 21-25, 2002. International Conference on Harmful Algae (10Th : 2002 : St. Pete Beach, Florida)|October 6, 2015
An Epidemiologic Approach to the Study of Aerosolized Florida Red TidesLora E Fleming, Lorraine C Backer, Barbara Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Lancet (London, England)|September 16, 2023
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on TuberculosisMichael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
Pageof 4